Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study.
Martino M, Gori M, Pitino A, Gentile M, Dattola A, Pontari A, Vigna E, Moscato T, Recchia AG, Barilla' S, Tripepi G, Morabito F. Martino M, et al. Among authors: dattola a. Biol Blood Marrow Transplant. 2017 Jul;23(7):1215-1220. doi: 10.1016/j.bbmt.2017.03.024. Epub 2017 Mar 24. Biol Blood Marrow Transplant. 2017. PMID: 28344060 Free article.
Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control.
Martino M, Moscato T, Barillà S, Dattola A, Pontari A, Fedele R, Furlò G, Marzia Stilo C, Alberto Gallo G, Tripepi G. Martino M, et al. Among authors: dattola a. Transfusion. 2015 Aug;55(8):2032-8. doi: 10.1111/trf.13117. Epub 2015 Apr 9. Transfusion. 2015. PMID: 25857853
Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34+ Cell and Platelet Counts.
Martino M, Gori M, Moscato T, Naso V, Ferreri A, Provenzano F, Loteta B, Sanguedolce MC, Console G, Dattola A, Pucci G, Gentile M, Morabito A, Recchia AG, Tripepi G, Pitino A. Martino M, et al. Among authors: dattola a. Biol Blood Marrow Transplant. 2019 Aug;25(8):1586-1591. doi: 10.1016/j.bbmt.2019.04.011. Epub 2019 Apr 17. Biol Blood Marrow Transplant. 2019. PMID: 31002994 Free article. Clinical Trial.
Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimen.
Fedele R, Messina G, Martinello T, Gallo GA, Pontari A, Moscato T, Console G, Dattola A, Princi D, Cuzzola M, Alati C, Ronco F, Molica S, Irrera G, Martino M. Fedele R, et al. Among authors: dattola a. Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):493-500. doi: 10.1016/j.clml.2014.04.006. Epub 2014 Jun 11. Clin Lymphoma Myeloma Leuk. 2014. PMID: 25034142
Tildrakizumab and Quality of Life: Deep Dive into the Impact of Psoriasis and Treatment on Different Domains-Should Psychosocial Life Impairment Be Considered a Comorbidity?
Licata G, Di Brizzi EV, Castelli F, Giuffrida G, Stroppiana E, Dattola A, Richetta AG, De Col E, Peila R, Siliquini N, Solaroli C, Zanetta R, Cerulli E, Galdo G, Giordano D, Faure E, Papaianni V, Pertusi G, Uzzauto MT, Loconsole F, Zichichi L. Licata G, et al. Among authors: dattola a. J Clin Med. 2025 Jan 2;14(1):223. doi: 10.3390/jcm14010223. J Clin Med. 2025. PMID: 39797306 Free PMC article.
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study.
Bernardini N, Dattola A, Rossi R, Pagnanelli G, Amerio P, Atzori L, Mugheddu C, Lora V, Giordano D, Guacci LF, Persechino S, Richetta AG, Skroza N, Potenza C. Bernardini N, et al. Among authors: dattola a. J Pers Med. 2024 Dec 22;14(12):1169. doi: 10.3390/jpm14121169. J Pers Med. 2024. PMID: 39728081 Free PMC article.
130 results